Dr. Norvell Coots is now the president and CEO of Holy Cross Health, a two-hospital system based in Silver Spring, Md., part of Trinity Health.
The helium shortage is no more—thanks to a device using some duct tape, plastic piping, a folding table and some other decidedly low-tech components.
Midwest Orthopaedics at Rush University Medical Center in Chicago will offer Canadians a flat fee for orthopedic procedures, which have one of the longest wait times for treatment in Canada.
The exit of Britain from the EU could prove disastrous for the nation's largest employer, its national healthcare system and industry. Experts predict that everything from medical professional staffing to regulations on drugs and devices will most certainly change, and most, for the worse.
It's well-known that Americans pay more for healthcare and drugs than many other nations, and a recent study confirms that the trend is the same when it comes to oncology drugs.
Patently perturbed: Trans-Pacific Partnership trade deal raises fears about drug patent periods, higher costs
Multilateral trade deals—such as the Trans-Pacific Partnership touted by President Barack Obama on his recent trip through Asia—are usually of little concern or consequence to healthcare stakeholders. But the TPP could affect pharmaceutical pricing around the globe.
Game of Thrones” fans are all too familiar with the character known as the Mountain. The hulking giant is perhaps best-known for his, uh, crushing victory over Prince Oberyn Martell.
If fear of flying mortarboards figures prominently in your phobias, then the University of East Anglia is on your side.
Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
French officials ruffled the feathers of foodies this month when they announced that foie gras, the luxury pâté made from the fattened duck or goose liver, would not be produced for three months.
President Obama's upcoming visit to Hiroshima in pursuit of a nuclear weapon-free world will unleash uncomfortable emotions on both sides of the Pacific. He ought to note what survivors of the blast taught mankind about the long-term effects of radiation exposure and the threat posed by nuclear war.
The World Health Organization—the central coordinating body for international health within the United Nations' system, which employs more than 7,000 people in 150 offices around the world—is due for a new chief executive.